{"rows":[{"id":2283,"title":"Psilocybin Therapeutic Research: The Present and Future Paradigm.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2020-04-09","publication_year":2020,"doi":"10.1021/acsmedchemlett.0c00048","pubmed_id":"32292538","openalex_id":"https://openalex.org/W3009264042","source_url":"https://pubmed.ncbi.nlm.nih.gov/32292538/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32292538","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32292538/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32292538","source_url":"https://pubmed.ncbi.nlm.nih.gov/32292538/","doi":"10.1021/acsmedchemlett.0c00048","pmid":"32292538","publication_date":"2020-04-09","importer_version":"2.1.3","text_redistributed":false}},{"id":1469,"title":"Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2023-06-08","publication_year":2023,"doi":"10.1021/acsmedchemlett.3c00168","pubmed_id":"37312838","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37312838/","substance_tags":"psilocybin,psilocin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Drug Interactions,Microbiome,Immune Function","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:15","bibtex":null,"source_record_id":"PMID:37312838","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37312838/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37312838","source_url":"https://pubmed.ncbi.nlm.nih.gov/37312838/","doi":"10.1021/acsmedchemlett.3c00168","pmid":"37312838","publication_date":"2023-06-08","importer_version":"2.1.3","text_redistributed":false}},{"id":1358,"title":"Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2023-10-12","publication_year":2023,"doi":"10.1021/acsmedchemlett.3c00390","pubmed_id":"37849550","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37849550/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37849550","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37849550/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37849550","source_url":"https://pubmed.ncbi.nlm.nih.gov/37849550/","doi":"10.1021/acsmedchemlett.3c00390","pmid":"37849550","publication_date":"2023-10-12","importer_version":"2.1.3","text_redistributed":false}},{"id":1197,"title":"Pioneering Methods in Brain Optimization and Mental Health Treatment.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2024-03-14","publication_year":2024,"doi":"10.1021/acsmedchemlett.4c00058","pubmed_id":"38505858","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/38505858/","substance_tags":"psilocybin,psilocin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:38505858","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38505858/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38505858","source_url":"https://pubmed.ncbi.nlm.nih.gov/38505858/","doi":"10.1021/acsmedchemlett.4c00058","pmid":"38505858","publication_date":"2024-03-14","importer_version":"2.1.3","text_redistributed":false}},{"id":1109,"title":"Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2024-06-13","publication_year":2024,"doi":"10.1021/acsmedchemlett.4c00181","pubmed_id":"38894903","openalex_id":"https://openalex.org/W4396721972","source_url":"https://pubmed.ncbi.nlm.nih.gov/38894903/","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Emotional Processing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:38894903","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38894903/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38894903","source_url":"https://pubmed.ncbi.nlm.nih.gov/38894903/","doi":"10.1021/acsmedchemlett.4c00181","pmid":"38894903","publication_date":"2024-06-13","importer_version":"2.1.3","text_redistributed":false}},{"id":1022,"title":"Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2024-09-12","publication_year":2024,"doi":"10.1021/acsmedchemlett.4c00412","pubmed_id":"39291007","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39291007/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Resilience","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:39291007","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39291007/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39291007","source_url":"https://pubmed.ncbi.nlm.nih.gov/39291007/","doi":"10.1021/acsmedchemlett.4c00412","pmid":"39291007","publication_date":"2024-09-12","importer_version":"2.1.3","text_redistributed":false}},{"id":1021,"title":"Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2024-09-12","publication_year":2024,"doi":"10.1021/acsmedchemlett.4c00414","pubmed_id":"39291015","openalex_id":"https://openalex.org/W4401734470","source_url":"https://pubmed.ncbi.nlm.nih.gov/39291015/","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Mechanism of Action,Emotional Processing,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:39291015","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39291015/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39291015","source_url":"https://pubmed.ncbi.nlm.nih.gov/39291015/","doi":"10.1021/acsmedchemlett.4c00414","pmid":"39291015","publication_date":"2024-09-12","importer_version":"2.1.3","text_redistributed":false}},{"id":957,"title":"Expanding the Therapeutic Horizons of Psilocybin in Mental Health.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2024-11-14","publication_year":2024,"doi":"10.1021/acsmedchemlett.4c00488","pubmed_id":"39563826","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39563826/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39563826","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39563826/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39563826","source_url":"https://pubmed.ncbi.nlm.nih.gov/39563826/","doi":"10.1021/acsmedchemlett.4c00488","pmid":"39563826","publication_date":"2024-11-14","importer_version":"2.1.3","text_redistributed":false}},{"id":925,"title":"Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2024-12-12","publication_year":2024,"doi":"10.1021/acsmedchemlett.4c00519","pubmed_id":"39691516","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39691516/","substance_tags":"psilocin","topic_tags":"Depression,Anxiety,Addiction,Review Article,Animal Study","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:05","bibtex":null,"source_record_id":"PMID:39691516","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39691516/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39691516","source_url":"https://pubmed.ncbi.nlm.nih.gov/39691516/","doi":"10.1021/acsmedchemlett.4c00519","pmid":"39691516","publication_date":"2024-12-12","importer_version":"2.1.3","text_redistributed":false}},{"id":817,"title":"Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2025-02-13","publication_year":2025,"doi":"10.1021/acsmedchemlett.5c00031","pubmed_id":"39967620","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39967620/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39967620","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39967620/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39967620","source_url":"https://pubmed.ncbi.nlm.nih.gov/39967620/","doi":"10.1021/acsmedchemlett.5c00031","pmid":"39967620","publication_date":"2025-02-13","importer_version":"2.1.3","text_redistributed":false}},{"id":700,"title":"Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2025-05-08","publication_year":2025,"doi":"10.1021/acsmedchemlett.5c00182","pubmed_id":"40365378","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40365378/","substance_tags":"psilocybin","topic_tags":"Chronic Pain","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40365378","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40365378/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40365378","source_url":"https://pubmed.ncbi.nlm.nih.gov/40365378/","doi":"10.1021/acsmedchemlett.5c00182","pmid":"40365378","publication_date":"2025-05-08","importer_version":"2.1.3","text_redistributed":false}},{"id":519,"title":"Therapeutic Divergence in 5-HTA Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.","authors":"Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2025-09-11","publication_year":2025,"doi":"10.1021/acsmedchemlett.5c00475","pubmed_id":"40959252","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40959252/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40959252","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40959252/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40959252","source_url":"https://pubmed.ncbi.nlm.nih.gov/40959252/","doi":"10.1021/acsmedchemlett.5c00475","pmid":"40959252","publication_date":"2025-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":439,"title":"Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory Innovations.","authors":"Renner AC, Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2025-11-13","publication_year":2025,"doi":"10.1021/acsmedchemlett.5c00597","pubmed_id":"41256977","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41256977/","substance_tags":"psilocin","topic_tags":"Neuroplasticity,Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41256977","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41256977/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41256977","source_url":"https://pubmed.ncbi.nlm.nih.gov/41256977/","doi":"10.1021/acsmedchemlett.5c00597","pmid":"41256977","publication_date":"2025-11-13","importer_version":"2.1.3","text_redistributed":false}},{"id":438,"title":"Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.","authors":"Renner AC, Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2025-11-13","publication_year":2025,"doi":"10.1021/acsmedchemlett.5c00595","pubmed_id":"41256989","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41256989/","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41256989","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41256989/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41256989","source_url":"https://pubmed.ncbi.nlm.nih.gov/41256989/","doi":"10.1021/acsmedchemlett.5c00595","pmid":"41256989","publication_date":"2025-11-13","importer_version":"2.1.3","text_redistributed":false}},{"id":398,"title":"Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.","authors":"Renner AC, Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2025-12-11","publication_year":2025,"doi":"10.1021/acsmedchemlett.5c00661","pubmed_id":"41404010","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41404010/","substance_tags":"psilocin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:41404010","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41404010/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41404010","source_url":"https://pubmed.ncbi.nlm.nih.gov/41404010/","doi":"10.1021/acsmedchemlett.5c00661","pmid":"41404010","publication_date":"2025-12-11","importer_version":"2.1.3","text_redistributed":false}},{"id":328,"title":"Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations.","authors":"Renner AC, Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2026-01-08","publication_year":2026,"doi":"10.1021/acsmedchemlett.5c00714","pubmed_id":"41531985","openalex_id":"https://openalex.org/W4417363285","source_url":"https://pubmed.ncbi.nlm.nih.gov/41531985/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:53","bibtex":null,"source_record_id":"PMID:41531985","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41531985/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41531985","source_url":"https://pubmed.ncbi.nlm.nih.gov/41531985/","doi":"10.1021/acsmedchemlett.5c00714","pmid":"41531985","publication_date":"2026-01-08","importer_version":"2.1.3","text_redistributed":false}},{"id":276,"title":"Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics.","authors":"Renner AC, Kargbo RB","journal":"ACS medicinal chemistry letters","publication_date":"2026-02-12","publication_year":2026,"doi":"10.1021/acsmedchemlett.5c00780","pubmed_id":"41704348","openalex_id":"https://openalex.org/W7122597626","source_url":"https://pubmed.ncbi.nlm.nih.gov/41704348/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41704348","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41704348/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41704348","source_url":"https://pubmed.ncbi.nlm.nih.gov/41704348/","doi":"10.1021/acsmedchemlett.5c00780","pmid":"41704348","publication_date":"2026-02-12","importer_version":"2.1.3","text_redistributed":false}}],"total":17,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"ACS medicinal chemistry letters","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}